HRT Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Buy
+10,500
New +$3.45M 0.01% 1300
2023
Q4
Sell
-2,700
Closed -$1.18M 2495
2023
Q3
$1.18M Buy
2,700
+1,200
+80% +$544K 0.01% 885
2023
Q2
$666K Sell
1,500
-3,300
-69% -$1.52M 0.01% 1201
2023
Q1
$2.21M Sell
4,800
-6,600
-58% -$3.14M 0.03% 541
2022
Q4
$5.85M Buy
11,400
+9,000
+375% +$4.57M 0.08% 222
2022
Q3
$1.09M Sell
2,400
-2,000
-45% -$957K 0.01% 858
2022
Q2
$2.12M Buy
4,400
+1,500
+52% +$742K 0.02% 543
2022
Q1
$1.42M Buy
+2,900
New +$1.33M 0.01% 815
2021
Q4
Sell
-1,900
Closed -$708K 3387
2021
Q3
$708K Buy
1,900
+500
+36% +$190K ﹤0.01% 1701
2021
Q2
$534K Buy
1,400
+100
+8% +$38.2K ﹤0.01% 1709
2021
Q1
$466K Sell
1,300
-1,100
-46% -$354K ﹤0.01% 1845
2020
Q4
$770K Buy
2,400
+500
+26% +$153K 0.02% 804
2020
Q3
$510K Buy
+1,900
New +$511K 0.01% 864
2020
Q2
Sell
-2,300
Closed -$522K 1587
2020
Q1
$522K Buy
+2,300
New +$627K 0.03% 382
2019
Q4
Sell
-9,900
Closed -$2.38M 1272
2019
Q3
$2.38M Buy
+9,900
New +$2.71M 0.11% 143

Other funds holding ELV

HRT Financial's ELV Position: Q4 2025 in Review

HRT Financial sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 5,406 shares — an estimated $1.75M sold.

HRT Financial first reported a position in ELV in Q2 2015 and held it in 15 quarters. The position peaked at $25.6M in Q2 2023. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • HRT Financial reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 5,406 Elevance Health shares in Q4 2025, an estimated $1.75M.
  • HRT Financial first reported a position in Elevance Health in Q2 2015 and held it in 15 quarters.
  • HRT Financial's Elevance Health position peaked at $25.6M in Q2 2023.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.